Novavax Reports Second Quarter 2025 Financial Results and Operational HighlightsPRNewsWire • 08/06/25
Novavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks Investment Research • 07/30/25
Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical StudyPRNewsWire • 07/24/25
Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference TranscriptSeeking Alpha • 06/12/25
Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage studyReuters • 06/11/25
Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 TrialPRNewsWire • 06/11/25
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-upReuters • 06/10/25